The absolute previously infected novel coronavirus (COVID-19) was found in Wuhan, China,
in December 2019. The COVID-19 epidemic has spread to more than 220 nations and …

Abstract Introduction Artificial Intelligence-based Medical Devices (AI-based MDs) are
experiencing exponential growth in healthcare. This study aimed to investigate whether …

SARS-CoV-2 has infected over∼ 165 million people worldwide causing Acute Respiratory
Distress Syndrome (ARDS) and has killed∼ 3.4 million people. Artificial Intelligence (AI) has …

Diagnostic imaging is regarded as fundamental in the clinical work-up of patients with a
suspected or confirmed COVID-19 infection. Recent progress has been made in diagnostic …

Background Recently, artificial intelligence (AI)-based applications for chest imaging have
emerged as potential tools to assist clinicians in the diagnosis and management of patients …

The novel coronavirus disease, COVID-19, has rapidly and abruptly changed the world as
we knew it in 2020. It has become the most unprecedented challenge to analytic …

Background The role of computed tomography (CT) in the diagnosis and characterization of
coronavirus disease 2019 (COVID-19) pneumonia has been widely recognized. We …

Purpose To evaluate whether early chest computed tomography (CT) lesions quantified by
an artificial intelligence (AI)-based commercial software and blood test values at the initial …

Purpose To investigate the effect of vaccinations and boosters on the severity of COVID-19
pneumonia on CT scans during the period of Delta and Omicron variants. Methods …

Combating the COVID-19 epidemic has emerged as one of the most promising healthcare
the world's challenges have ever seen. COVID-19 cases must be accurately and quickly …